TickerFactsScreenerDevelopers

Tvardi Therapeutics, Inc. (TVRD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $4.10M2012: $1.12M2013: $12.36M2014: $52.66M2015: $15.10M2016: $12.09M2017: $9.39M2018: $15.08M2019: $18.30M2020: $31.68M2021: $13.45M2022: $63.74M2023: $51.77M2024: $31.61M2025: $20.73M$20.73M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$20.73M-34.4%
2024$31.61M-38.9%
2023$51.77M-18.8%
2022$63.74M+373.8%
2021$13.45M-57.5%
2020$31.68M+73.1%
2019$18.30M+21.4%
2018$15.08M+60.6%
2017$9.39M-22.4%
2016$12.09M-19.9%
2015$15.10M-71.3%
2014$52.66M+326.2%
2013$12.36M+1006.3%
2012$1.12M-72.7%
2011$4.10M—